NCT07197983 Automation of Oocyte and Embryo Vitrification
| NCT ID | NCT07197983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Conceivable Life Sciences |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 125 participants |
| Start Date | 2025-10-14 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 125 participants in total. It began in 2025-10-14 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Purpose: This study aims to test whether a new automated system can freeze human eggs and embryos as effectively as the current manual method performed by laboratory staff. Background: Currently, freezing eggs and embryos during fertility treatments (IVF/ICSI) is done entirely by hand by skilled embryologists. This manual process is time-consuming, requires extensive training, and outcomes can vary between different staff members. Automating this process could help standardize procedures, reduce costs, and potentially make fertility treatments more accessible to patients. What is Being Tested: The study will compare an automated freezing system (prototype designation PRESERVE-CR) against the standard manual freezing method. The key research question is: Can the automated system preserve eggs and embryos as successfully as experienced embryologists do by hand? How It Works: Patients undergoing IVF/ICSI treatment at CARE Fertility Manchester who consent to participate will have their surplus eggs and embryos (those not suitable for their treatment) divided into two groups. Some will be frozen using the traditional manual method, and some using the new automated system. Both groups will then be thawed to measure survival rates. Tests do not encompass any reproductive outcomes or the creation of embryos specifically for this research. Why This Matters: If successful, automated freezing could help reduce the workload on laboratory staff, standardize the freezing process across different clinics, potentially lower treatment costs, and make fertility treatments available to more people who need them. The study only uses oocytes and embryos which are unsuitable for patient treatment and that would otherwise be discarded, ensuring no impact on participants' actual fertility treatment.
Eligibility Criteria
Inclusion Criteria: * BMI: Between 20-35 kg/m² * Ovarian Reserve: Anti-Müllerian Hormone (AMH) ≥1.5 ng/mL Exclusion Criteria: * Low ovarian reserve * Surgical sperm retrieval required
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07197983 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 38 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07197983 currently recruiting?
Yes, NCT07197983 is actively recruiting participants. Contact the research team at giuseppe@conceivable.life for enrollment information.
Where is the NCT07197983 trial being conducted?
This trial is being conducted at Manchester, United Kingdom.
Who is sponsoring the NCT07197983 clinical trial?
NCT07197983 is sponsored by Conceivable Life Sciences. The trial plans to enroll 125 participants.